Alnylam Issues 2023 Corporate Responsibility Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 219.89 +0.17 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $219.72 | 52 Week High | $109.10 | |||
| Open | $218.36 | 52 Week Low | $31.38 | |||
| Day High | $222.08 | P/E | N/A | |||
| Day Low | $215.46 | EPS | $-1.45 | |||
| Volume | 1,281,643 | |||||
